We apologize! The document was not able to download due to an unknown error. Our team has been notified and we will fix it as soon as possible. Fill out the form below, and we will send you the document as soon as we can!
RESOMER® RG 504
RESOMER® RG 504 is an innovative pharmaceutical controlled-release agent containing a medium-viscosity blend of 50 mol % D,L-Lactide and 50 mol % Glycolide with a degradation period of 3 months maximum.
RESOMER® RG 504 is a lactide-based copolymer containing a purified poly(D,L-lactide-co-glycolide) (CAS no. 26780-50-7) for a minimal residual monomer content and advanced performance. RESOMER® RG 504 is specially recommended for pharmaceutical applications where controlled drug release is essential, including long-acting medication delivery systems, in-situ depot formulations, drug-loaded implants, and more, offering compatibility with a range of pharmaceutical substances, small molecules, proteins, and peptides. RESOMER® RG 504 is recommended for processing by injection molding and provides a degradation period of 3 months max.
RESOMER® RG 504 complies with FDA, GMP, EHS, DIN ISO 9001, MAF, and DMF regulations.
RESOMER® polymers have been purified for a reduced residual monomer content and are available in a variety of molecular weights and viscosity ranges to meet application needs. All polymer properties can also be adjusted to match formulation requirements.
Specifications
Physical state: Solid Form: Powder granules Color: White to off-white Inherent viscosity (dl/g): 0.45─0.60 Degradation time: <3 months CAS No. 26780-50-7
Primary Chemistry: Poly(D,L-lactide-co-glycolide)
Features & Benefits
Solvent-purified co-polymer 50:50 D,L-lactide:Glycolide ratio Alkyl ester terminated 3 month degradation period Bioabsorbable Biodegradable Processed by injection molding Completely metabolized by the body Ideal for terminal sterilization Suitable for use with small molecules, peptides, proteins, and other substances
Applications
Controlled release applications Microparticles and drug-loaded implants Long acting medication delivery formulations
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region:
English - United States
Hi, let us know if you have any questions as you visit our website.
